Showing 1 - 3 of 3 Research Library Publications
Posted: | Hanin Rashid, Christopher Runyon, Jesse Burk-Rafel, Monica M. Cuddy, Liselotte Dyrbye, Katie Arnhart, Ulana Luciw-Dubas, Hilit F. Mechaber, Steve Lieberman, Miguel Paniagua

Academic Medicine: Volume 97 - Issue 11S - Page S176

 

As Step 1 begins to transition to pass/fail, it is interesting to consider the impact of score goal on wellness. This study examines the relationship between goal score, gender, and students’ self-reported anxiety, stress, and overall distress immediately following their completion of Step 1.

Posted: | S. H. Felgoise, R. A. Feinberg, H. B. Stephens, P. Barkhaus, K. Boylan, J. Caress, Z. Simmons

Muscle Nerve, 58: 646-654

 

The Amyotrophic Lateral Sclerosis (ALS)‐Specific Quality of Life instrument and its revised version (ALSSQOL and ALSSQOL‐R) have strong psychometric properties, and have demonstrated research and clinical utility. This study aimed to develop a short form (ALSSQOL‐SF) suitable for limited clinic time and patient stamina.

Posted: | M. C. Edwards, A. Slagle, J. D. Rubright, R. J. Wirth

Qual Life Res 27, 1711–1720 (2018)

 

The US Food and Drug Administration (FDA), as part of its regulatory mission, is charged with determining whether a clinical outcome assessment (COA) is “fit for purpose” when used in clinical trials to support drug approval and product labeling. This paper provides a review (and some commentary) on the current state of affairs in COA development/evaluation/use with a focus on one aspect: How do you know you are measuring the right thing? In the psychometric literature, this concept is referred to broadly as validity and has itself evolved over many years of research and application.